Exact Therapeutics AS Stock

Exact Therapeutics AS Liabilities

The The Liabilities of Exact Therapeutics AS (EXTX.OL) as of Aug 15, 2026 is 36.69 M NOK. In the previous year, The Liabilities was 37.65 M NOK — a change of -2.56% (lower).

Liabilities

36.69 MNOK

YoY

-2.56%

Last updated:

In 2026, Exact Therapeutics AS's total liabilities amounted to 36.69 M NOK, a -2.56% difference from the 37.65 M NOK total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Exact Therapeutics AS Stock analysis

What does Exact Therapeutics AS do? Exact Therapeutics AS is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Exact Therapeutics AS's Liabilities

Exact Therapeutics AS's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Exact Therapeutics AS's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Exact Therapeutics AS's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Exact Therapeutics AS's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Exact Therapeutics AS’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Exact Therapeutics AS stock

The Liabilities of Exact Therapeutics AS is 36.69 M NOK in 2026.

The Liabilities of Exact Therapeutics AS changed from 37.65 M NOK to 36.69 M NOK, representing a -2.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Exact Therapeutics AS since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Exact Therapeutics AS historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Exact Therapeutics AS

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Exact Therapeutics AS